Good User Reputation for Irinotecan - Lurasidone Hydrochloride CAS 367514-88-3 API High Purity – Ruifu

Short Description:


Product Detail

Related Products

Product Tags

Related Video

Feedback (2)

To create far more benefit for customers is our company philosophy; customer growing is our working chase for Weight 266.25, 125971-94-0, Molecular Formula C20H20O9, President of our company, with whole staff, welcomes all buyers to visit our company and inspect. Let us cooperate hand in hand to make a good future.
Good User Reputation for Irinotecan - Lurasidone Hydrochloride CAS 367514-88-3 API High Purity – Ruifu Detail:

Manufacturer Supply with High Purity and Stable Quality
Lurasidone Hydrochloride (CAS 367514-88-3) Related Intermediates:
(1R,2R)-1,2-Cyclohexanedimethanol CAS 65376-05-8
(3aR,4S,7R,7aS)-rel-Hexahydro-4,7-methano-1H-isoindole-1,3(2H)-dione CAS 14805-29-9
Lurasidone Hydrochloride CAS 367514-88-3 API
High Quality, Commercial Production

Chemical Name Lurasidone Hydrochloride
Synonyms Lurasidone HCl; Latuda
CAS Number 367514-88-3
CAT Number RF-API64
Stock Status In Stock, Production Scale Up to Hundreds of Kilograms
Molecular Formula C28H36N4O2S
Molecular Weight 492.684
Melting Point 198.0~205.0°C
Shipping Condition Shipped Under Ambient Temperature
Brand Ruifu Chemical
Item Specifications
Appearance White or Off-White Crystalline Powder
NMR Consistent with Structure
Solubility Meets the Requirements
Max. Single Impurity ≤0.20%
Total Impurities ≤0.50%
Moisture (K.F) ≤1.0%
Residue of Ignition ≤0.20%
Heavy Metals ≤20ppm
Purity ≥99.0%
Test Standard Enterprise Standard
Usage API,  Atypical Antipsychotic Drug (AAPD)

Package: Bottle, Aluminium foil bag, Cardboard Drum, 25kg/Drum, or according to customer’s requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.

1

Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Lurasidone Hydrochloride (CAS 367514-88-3) with high quality, API.

Lurasidone Hydrochloride (CAS 367514-88-3) is an orally administered substance that belongs to the class of atypical antipsychotic drugs (AAPD), developed by Dainippon Sumitomo Pharma. It was approved by the U.S. Food and Drug Administration (FDA) for treatment of schizophrenia on October 29, 2010 and is currently pending approval for the treatment of bipolar disorder in the United States. It received approval by the EMA in 2014 for schizophrenia. Lurasidone has also been launched in a number of countries outside the US and EU, including Canada, where it is approved for both indications. It is produced through a multi-step chemical process.


Product detail pictures:

Good User Reputation for Irinotecan - Lurasidone Hydrochloride CAS 367514-88-3 API High Purity  – Ruifu detail pictures


Related Product Guide:

Which has a positive and progressive attitude to customer's desire, our corporation constantly improves our merchandise quality to satisfy the desires of consumers and further focuses on safety, reliability, environmental demands, and innovation of Good User Reputation for Irinotecan - Lurasidone Hydrochloride CAS 367514-88-3 API High Purity – Ruifu , The product will supply to all over the world, such as: Georgia, Bogota, Mongolia, Our items are exported worldwide. Our customers are always satisfied with our reliable quality, customer-oriented services and competitive prices. Our mission is "to continue to earn your loyalty by dedicating our efforts to the constant improvement of our merchandise and services in order to ensure the satisfaction of our end-users, customers, employees, suppliers and the worldwide communities in which we cooperate".
  • We are a small company that has just started, but we get the company leader's attention and gave us a lot of help. Hope we can make progress together!
    5 Stars By Quintina from Mumbai - 2017.05.02 11:33
    In China, we have many partners, this company is the most satisfying to us, reliable quality and good credit, it is worth appreciation.
    5 Stars By Tina from Turkey - 2017.06.29 18:55
    Write your message here and send it to us